Reining in the killers
Nature Immunology
March 24, 2014
How natural killer (NK) cells, which play important roles in destroying cancerous and virally infected cells in the body, are restrained is described in a paper published online this week in Nature Immunology. By better understanding how NK cells can be regulated, these cells’ function can be utilized for therapeutic purposes such as tumor cell killing.
Mark J Smyth and colleagues find that mouse and human NK cells have a little-known receptor molecule on their surface called CD96. By genetically removing CD96 on mouse NK cells, the authors see that NK cells become rampantly activated. While this can result in an over-exuberant and harmful inflammatory response, the hyperactive CD96-deficient NK cells are also far more efficient at killing cancer cells in several different mouse models.
doi: 10.1038/ni.2850
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature